SCHEMBL7992285

SCHEMBL7992285

CN(Cc1nc(O)c2c(ncn2Cc2ccc(C(C)(C)C)cc2)n1)C(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCC8 Q09428 1/20 0.41
KCNJ11 Q14654 1/20 0.41
NR1H4 Q96RI1 6/20 0.38
SLC6A4 P31645 2/20 0.37
HTR2C P28335 1/20 0.37
MEN1 O00255 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
EGLN3 Q9H6Z9 1/20 0.34
MCL1 Q07820 1/20 0.34
CACNA1G O43497 1/20 0.32
CACNA1B Q00975 1/20 0.32
CACNA1C Q13936 1/20 0.32
PTGER2 P43116 1/20 0.32
NR1I2 O75469 1/20 0.32
LMNA P02545 1/20 0.32
ADRA2A P08913 1/20 0.32
CYP2D6 P10635 1/20 0.32
ACHE P22303 1/20 0.32
SLC6A2 P23975 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987944 0.91 HTR2C (0.38) ABCC8KCNJ11SLC6A4HTR2CMCL1
SCHEMBL7974300 0.90 HTR2C (0.37) SLC6A4HTR2CMCL1CACNA1GCACNA1B
SCHEMBL7985457 0.90 HTR2C (0.46) SLC6A4HTR2CKMT2AMCL1HPGD
SCHEMBL7988121 0.85 SMN1; SMN2 (0.41) SLC6A4HTR2CMEN1KMT2AMCL1
SCHEMBL7975222 0.83 MCL1 (0.39) SLC6A4HTR2CMCL1LMNAHTR2A
SCHEMBL7988928 0.83 GAA (0.44) SLC6A4HTR2CMCL1PTGER2HPGD
SCHEMBL7992290 0.82 HPGD (0.42) ABCC8KCNJ11NR1H4SLC6A4HTR2C
SCHEMBL7988917 0.82 HTR2C (0.40) SLC6A4HTR2CKMT2AMCL1HPGD
SCHEMBL7984728 0.81 NR1H4 (0.41) ABCC8KCNJ11NR1H4MEN1RAB9A
SCHEMBL7991605 0.81 HTR2C (0.41) SLC6A4HTR2CMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed